Abstract Submissions

General Information

The EAC 2025 Annual Meeting will include poster presentations by allergists/immunologists and fellows-in-training, that will also feature a scientific program with interactive, problem-based learning and didactic lectures. We urge you to participate by submitting your clinical research findings for consideration by our Poster Review Committee. In preparing your abstract organize it into a statement of purpose; statement of methods; and summary of results in sufficient detail to support the conclusion reached.

 Once your abstract is accepted for the conference, you will be assigned a specific day (Friday or Saturday) to present your findings. Abstracts will will have the option to be published in Allergy & Asthma Proceedings.

Fellows-in-training: Abstract Submission fee is waived for presenting an abstract.

Due Date for Abstract Submissions: April 15, 2025

 Submit all printed abstracts to: GinnyLoiselle@easternallergyconference.org 

Poster size for display: 4 feet high by 6 feet long

• The abstract must adequately describe the objectives, methods, results, and conclusions so that the Abstract Committee may evaluate the quality of the work and      proposed presentation.
• The abstract title should fully reflect the content of the abstract body.
• A structured abstract format is required:            

                  ► Title           

                  ► Author line (affiliations will not be printed in the Program booklet)               

                  ► Introduction (background information and purpose of the project/study)            

                  ► Methods (study design, techniques)             

                  ► Results (summary of data)            

                  ► Conclusions             

                  ► Funding if appropriate

• Illustrations and tables will not be printed in the Program booklet but may be included in      your presentation poster.
• Supplementary data are not accepted under any circumstances.
• Abbreviations may be used in the abstract if such abbreviations are defined at their first mention.
• The abstract length is limited to 300 words. 
• Abstracts must be submitted in a word.DOC format
• Font size 12, New Times Roman, title and headings only in bold
• Authors are to be listed by First name, Last name, Highest degree (ie: John Smith, MD). Affiliations should not be included as they will not be printed in the Program Book. They are allowed in your final poster presentation.
• Authors are encouraged but not required to submit for peer review and publication, any subsequent full-length manuscripts which derive from the submitted abstract.
• Each abstract submission must specify a corresponding author, to whom all correspondence about the abstract will be directed.
• Abstracts are submitted for poster presentation. 
• The presenter of each accepted abstract must register for the scientific meeting in the standard fashion see EasternAllergyConference.org  
• Wherever possible, non-commercial (generic) names must be used in all abstracts and posters. The Editorial staff may request a revised submission of the abstract to enforce      compliance with this ACCME requirement.
• All authors must agree to disclose all non-FDA approved use of FDA approved drugs during the abstract submission process as well as in the actual presentation (oral or poster). 
• The authors must accept sole responsibility for the statements in their submitted abstract.

** All abstracts will be posted on the EAC website at the conclusion of each meeting unless otherwise noted

**please see attached submission form below